Interferon Gamma 1-b Clinical Trials
2 recruitingDrug
Phase 32Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized Bayesian Double-blind Controlled Trial Versus Placebo
Post-aggressive ImmunosuppressionAdult Patients Admitted to Intensive Care With Initial Severity (SOFA of the First 24 Hours Post-admission ≥ 6Adult Under Mechanical Ventilation, and Presenting an mHLA-DR Less Than 8,000AB/C
Assistance Publique - Hôpitaux de Paris170 enrolled2 locationsNCT06694740
Recruiting
Phase 3
Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppression
Sustained Immunosuppression
University Hospital, Limoges326 enrolled23 locationsNCT06774235